Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral Sepsis

Pediatrics. 2020 Jan;145(1):e20191632. doi: 10.1542/peds.2019-1632. Epub 2019 Dec 11.

Abstract

Adenovirus infection is common in childhood and is generally associated with self-limited disease. Cidofovir, a viral DNA polymerase inhibitor, is used to treat adenovirus infection in select populations but is not often recommended for immunocompetent patients because of limited antiviral activity and nephrotoxicity. Here, we report a case of fulminant adenovirus infection associated with lymphopenia and multiple organ failure requiring extracorporeal membrane oxygenation support in a previously healthy child. After 1 week of supportive therapy, the patient had persistent organ failure and continued to have adenoviremia of >560 000 copies per mL. Weekly doses of cidofovir with concurrent probenecid for renal protection was initiated. Adenovirus blood load declined after the first cidofovir dose, becoming undetectable after 3 doses. The patient was successfully decannulated from extracorporeal membrane oxygenation, extubated, and eventually discharged at his functional baseline without need for ongoing respiratory support. Lymphopenia improved after viremia resolved, and a subsequent immunologic workup revealed no evidence of primary immunodeficiency. The viral isolate was genotyped as adenovirus type 7. This case reveals the successful use of cidofovir for management of severe adenovirus infection in a previously healthy child. To date, there are no universally accepted recommendations for the use of cidofovir in this population. Further study is warranted to determine the potential role of cidofovir in treating severe adenovirus infections in immunocompetent children.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Adenoviridae / isolation & purification
  • Adenoviridae Infections / complications
  • Adenoviridae Infections / drug therapy*
  • Antiviral Agents / therapeutic use*
  • Child, Preschool
  • Cidofovir / therapeutic use*
  • Combined Modality Therapy
  • Consciousness Disorders / etiology
  • Extracorporeal Membrane Oxygenation
  • Humans
  • Immunocompetence
  • Male
  • Multiple Organ Failure / etiology
  • Nose / virology
  • Patient Acuity
  • Pneumonia, Viral / diagnostic imaging
  • Polymerase Chain Reaction
  • Radiography, Thoracic
  • Respiratory Distress Syndrome / etiology
  • Respiratory Distress Syndrome / therapy
  • Shock / etiology

Substances

  • Antiviral Agents
  • Cidofovir